查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1612620

血液篩檢市場：按產品和服務、技術、最終用戶分類 - 全球預測 2025-2030

Blood Screening Market by Product & Service (Instruments, Outright Purchase, Reagents & Kits), Technology (ELISA, NAT, NGS), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年血液篩檢市場規模預估為49億美元，預估2024年將達53.1億美元，複合年成長率為8.74%，到2030年將達88.2億美元。

血液篩檢是一個重要的診斷過程，旨在透過檢測感染疾病、病原體和其他異常情況來確保血液安全。這個過程對於捐血和醫療診斷至關重要，旨在預防輸血傳播的感染疾病，並有助於早期發現愛滋病毒、肝炎和梅毒等疾病。血液篩檢具有廣泛的最終用途，包括醫院、血庫和診斷實驗室，為疾病監測和公共衛生保護提供了顯著的好處。全球健康和安全意識的提高以及對疾病早期檢測的需求不斷增加是關鍵的成長動力。次世代定序和分子診斷等技術的進步為市場擴張提供了有希望的可能性。自動化和人工智慧創新提供了提高篩檢準確性和效率並解決錯誤率和處理時間等挑戰的機會。然而，市場面臨一些限制，例如與先進篩檢技術相關的高成本以及減緩創新的嚴格監管環境。低收入和中等收入國家的最終用戶經常與昂貴的篩檢方法作鬥爭，凸顯了持續存在的挑戰。此外，病原體突變率的複雜性需要持續的研究和開發以維持篩檢的有效性。為了利用新的商機，公司應該投資於具有成本效益的快速測試，並考慮與高科技公司合作以推進人工智慧驅動的診斷。研究可以同時檢測多種病原體的多重測試有可能徹底改變篩檢效率和安全性。對血液篩檢重要性的持續教育以及政府透過優惠政策提供的支持可能會進一步推動市場成長。結合這些策略的積極主動的方法將有助於克服當前的市場障礙，推動血液篩檢市場的業務顯著成長，同時滿足對全面健康和安全解決方案不斷成長的需求。

主要市場統計
基準年[2023] 49億美元
預測年份 [2024] 53.1億美元
預測年份 [2030] 88.2億美元
複合年成長率（%） 8.74%

市場動態：快速發展的血液篩檢市場的關鍵市場洞察

供需的動態交互作用正在改變血液篩檢市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 捐血需求增加，捐血人數增加
    • 感染疾病的流行和新病原體的出現
    • 降低價格並更多地採用核酸檢測進行血液篩檢
  • 市場限制因素
    • 血液篩檢診斷藥物價格上漲
  • 市場機會
    • 血液篩檢設備的技術進步
    • 改進血液篩檢的 POC 診斷方法
  • 市場挑戰
    • 缺乏有關血液篩檢的立法和政策

波特五力：駕馭血液篩檢市場的策略工具

波特的五力架構是了解血液篩檢市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解血液篩檢市場的外部影響

外部宏觀環境因素在塑造血液篩檢市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解血液篩檢市場的競爭格局

血液篩檢市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣血液篩檢市場供應商的績效評估

FPNV定位矩陣是評估血液篩檢市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了血液篩檢市場的成功之路

血液篩檢市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 捐血需求和捐血次數增加
      • 感染疾病的傳播和新病原體的出現
      • 提高血液篩檢核酸檢測的可負擔性和採用率
    • 抑制因素
      • 血液篩檢診斷費用高
    • 機會
      • 血液篩檢設備的技術進步
      • 改善血液篩檢POC 診斷
    • 任務
      • 缺乏血液篩檢的法律、法規和政策
  • 市場區隔分析
    • 產品：更多採用設備和耗材來執行準確的測試
    • 技術：酵素免疫分析法和質譜分析的發展
    • 用途：它在檢測感染疾病和癌症方面具有重要用途，並可防止感染傳播。
    • 最終用戶：醫院和實驗室更多地使用血液篩檢
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章血液篩檢市場：依產品及服務分類

  • 裝置
  • 完成購買
  • 試劑和套件
    • ELISA 試劑和套件
      • 共軛形式
      • 控制
      • 免疫吸附劑
      • 樣品稀釋液和清洗液
      • 基材
    • NAT 試劑和套件
      • 緩衝液、核苷酸、溶液
      • 酶和聚合酵素
      • 標記和檢測試劑
      • 探針和引子
      • 標準與管理

第7章血液篩檢市場：依技術分類

  • 酵素連結免疫吸附試驗
    • 化學冷光免疫檢測
    • 比色免疫檢測
    • 螢光免疫分析法
  • NAT
    • 即時聚合酵素鏈鎖反應
    • 轉錄介導的擴增
  • 下一代種子
  • 快速測試
  • 西方墨點法分析

第8章血液篩檢市場：依最終用戶分類

  • 血庫
  • 醫院

第9章美洲血液篩檢市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太血液篩檢市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的血液篩檢市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Harbinger Health 籌集了 1.4 億美元用於血液癌症篩檢測試的研究
    • Oxford Biodynamics 宣佈在美國開始為有攝護腺癌風險的男性提供 Episwitch 攝護腺篩檢血液測試，準確率達 94%
    • 沃爾格林和 FreeNome 促進癌症血液檢測試驗
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Alfa Scientific Designs, Inc.
  • Becton, Dickinson And Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMerieux SA
  • Danaher Corporation
  • DiaSorin SpA
  • Environmental & Scientific Instruments Co.
  • F. Hoffmann-La Roche AG
  • GE HealthCare Technologies, Inc.
  • GFE
  • Grifols, SA
  • Immucor, Inc.
  • Laboratory Corporation of America Holdings
  • Lifeloc Technologies, Inc
  • Omega Laboratories, Inc.
  • OraSure Technologies, Inc.
  • Ortho Clinical Diagnostics, Inc.
  • PerkinElmer, Inc.
  • PixCell Medical Technologies Ltd.
  • Premier Biotech, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc
Product Code: MRR-374DB5A06BE3

The Blood Screening Market was valued at USD 4.90 billion in 2023, expected to reach USD 5.31 billion in 2024, and is projected to grow at a CAGR of 8.74%, to USD 8.82 billion by 2030.

Blood screening is a critical diagnostic process designed to ensure blood safety by detecting infectious diseases, pathogens, and other irregularities. This process is essential for both blood donations and medical diagnostics, aiming to prevent transfusion-transmitted infections and contribute to early detection of diseases such as HIV, hepatitis, and syphilis. Applications of blood screening span across diverse end-use settings including hospitals, blood banks, and diagnostic laboratories, offering significant benefits in terms of disease surveillance and public health protection. Enhanced global awareness on health and safety, coupled with growing demand for early disease detection, are major growth drivers. Advances in technology, like next-gen sequencing and molecular diagnostics, offer promising potential for market expansion. Innovations in automation and AI present opportunities to enhance screening accuracy and efficiency, addressing challenges like error rates and process time. However, the market faces limitations such as high costs associated with advanced screening technologies and stringent regulatory landscapes that can slow down innovation. End-users in low-to-middle income countries often struggle with cost-prohibitive screening methods, highlighting an ongoing challenge. Additionally, the complexity of pathogen mutation rates necessitates ongoing research and development to maintain screening efficacy. To capitalize on emerging opportunities, companies should invest in cost-effective, rapid testing methods, potentially through partnerships with tech firms to advance AI-driven diagnostics. Research into multiplex testing, enabling simultaneous detection of multiple pathogens, could revolutionize screening efficiency and safety. Continuous education on the importance of blood screening and government support through favorable policies could further catalyze market growth. A proactive approach combining these strategies could help overcome current market obstacles while aligning with the increasing demand for comprehensive health safety solutions, thus facilitating significant business growth in the blood screening market.

KEY MARKET STATISTICS
Base Year [2023] USD 4.90 billion
Estimated Year [2024] USD 5.31 billion
Forecast Year [2030] USD 8.82 billion
CAGR (%) 8.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Screening Market

The Blood Screening Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for donated blood and rising number of blood donations
    • Rising prevalence of infectious diseases and the emergence of newer pathogens
    • Increase in affordability and adoption of nucleic acid test for blood screening
  • Market Restraints
    • High price for blood screening diagnostics
  • Market Opportunities
    • Technological Advancements in blood screening devices
    • Improved POC diagnostics for blood screening
  • Market Challenges
    • Lack of legislation, regulations, and policies on blood screening

Porter's Five Forces: A Strategic Tool for Navigating the Blood Screening Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Screening Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Screening Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Screening Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Screening Market

A detailed market share analysis in the Blood Screening Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Screening Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Screening Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Screening Market

A strategic analysis of the Blood Screening Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alfa Scientific Designs, Inc., Becton, Dickinson And Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux SA, Danaher Corporation, DiaSorin S.p.A., Environmental & Scientific Instruments Co., F. Hoffmann-La Roche AG, GE HealthCare Technologies, Inc., GFE, Grifols, S.A., Immucor, Inc., Laboratory Corporation of America Holdings, Lifeloc Technologies, Inc, Omega Laboratories, Inc., OraSure Technologies, Inc., Ortho Clinical Diagnostics, Inc., PerkinElmer, Inc., PixCell Medical Technologies Ltd., Premier Biotech, Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Trinity Biotech Plc.

Market Segmentation & Coverage

This research report categorizes the Blood Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Instruments, Outright Purchase, and Reagents & Kits. The Reagents & Kits is further studied across ELISA Reagents & Kits and NAT Reagents & Kits. The ELISA Reagents & Kits is further studied across Conjugates, Controls, Immunosorbents, Sample Diluents & Wash Solutions, and Substrates. The NAT Reagents & Kits is further studied across Buffers, Nucleotides, & Solutions, Enzymes & Polymerases, Labeling & Detection Reagents, Probes & Primers, and Standards & Controls.
  • Based on Technology, market is studied across ELISA, NAT, NGS, Rapid Tests, and Western Blot Assays. The ELISA is further studied across Chemiluminescent Immunoassay, Colorimetric Immunoassay, and Fluorescent immunoassay. The NAT is further studied across Real-Time Polymerase Chain Reaction and Transcription-Mediated Amplification.
  • Based on End-User, market is studied across Blood Banks and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for donated blood and rising number of blood donations
      • 5.1.1.2. Rising prevalence of infectious diseases and the emergence of newer pathogens
      • 5.1.1.3. Increase in affordability and adoption of nucleic acid test for blood screening
    • 5.1.2. Restraints
      • 5.1.2.1. High price for blood screening diagnostics
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements in blood screening devices
      • 5.1.3.2. Improved POC diagnostics for blood screening
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of legislation, regulations, and policies on blood screening
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rising adoption of instruments and consumables for conducting accurate tests
    • 5.2.2. Technology: Development of enzyme-linked immunosorbent assay and mass spectrometry technology
    • 5.2.3. Application: Significant applications of infectious disease and cancer screening to prevent the spread of infections
    • 5.2.4. End-User: Increasing use of blood screening in hospitals and laboratories
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Screening Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Outright Purchase
  • 6.4. Reagents & Kits
    • 6.4.1. ELISA Reagents & Kits
      • 6.4.1.1. Conjugates
      • 6.4.1.2. Controls
      • 6.4.1.3. Immunosorbents
      • 6.4.1.4. Sample Diluents & Wash Solutions
      • 6.4.1.5. Substrates
    • 6.4.2. NAT Reagents & Kits
      • 6.4.2.1. Buffers, Nucleotides, & Solutions
      • 6.4.2.2. Enzymes & Polymerases
      • 6.4.2.3. Labeling & Detection Reagents
      • 6.4.2.4. Probes & Primers
      • 6.4.2.5. Standards & Controls

7. Blood Screening Market, by Technology

  • 7.1. Introduction
  • 7.2. ELISA
    • 7.2.1. Chemiluminescent Immunoassay
    • 7.2.2. Colorimetric Immunoassay
    • 7.2.3. Fluorescent immunoassay
  • 7.3. NAT
    • 7.3.1. Real-Time Polymerase Chain Reaction
    • 7.3.2. Transcription-Mediated Amplification
  • 7.4. NGS
  • 7.5. Rapid Tests
  • 7.6. Western Blot Assays

8. Blood Screening Market, by End-User

  • 8.1. Introduction
  • 8.2. Blood Banks
  • 8.3. Hospitals

9. Americas Blood Screening Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Blood Screening Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Blood Screening Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Harbinger Health Raises $140M to Study Blood-Based Cancer Screening Test
    • 12.3.2. Oxford Biodynamics Announces US Launch of its 94% Accurate EpiSwitch Prostate Screening Blood Test to Men With Prostate Cancer Risk
    • 12.3.3. Walgreens and Freenome to Advance Blood-Based Test Trials For Cancer
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Alfa Scientific Designs, Inc.
  • 3. Becton, Dickinson And Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Bio-Techne Corporation
  • 6. bioMerieux SA
  • 7. Danaher Corporation
  • 8. DiaSorin S.p.A.
  • 9. Environmental & Scientific Instruments Co.
  • 10. F. Hoffmann-La Roche AG
  • 11. GE HealthCare Technologies, Inc.
  • 12. GFE
  • 13. Grifols, S.A.
  • 14. Immucor, Inc.
  • 15. Laboratory Corporation of America Holdings
  • 16. Lifeloc Technologies, Inc
  • 17. Omega Laboratories, Inc.
  • 18. OraSure Technologies, Inc.
  • 19. Ortho Clinical Diagnostics, Inc.
  • 20. PerkinElmer, Inc.
  • 21. PixCell Medical Technologies Ltd.
  • 22. Premier Biotech, Inc.
  • 23. Siemens Healthineers AG
  • 24. Thermo Fisher Scientific Inc.
  • 25. Trinity Biotech Plc

LIST OF FIGURES

  • FIGURE 1. BLOOD SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD SCREENING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD SCREENING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BLOOD SCREENING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BLOOD SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BLOOD SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD SCREENING MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD SCREENING MARKET SIZE, BY OUTRIGHT PURCHASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD SCREENING MARKET SIZE, BY CONJUGATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD SCREENING MARKET SIZE, BY CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD SCREENING MARKET SIZE, BY IMMUNOSORBENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD SCREENING MARKET SIZE, BY SAMPLE DILUENTS & WASH SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD SCREENING MARKET SIZE, BY SUBSTRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD SCREENING MARKET SIZE, BY BUFFERS, NUCLEOTIDES, & SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD SCREENING MARKET SIZE, BY ENZYMES & POLYMERASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD SCREENING MARKET SIZE, BY LABELING & DETECTION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD SCREENING MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD SCREENING MARKET SIZE, BY STANDARDS & CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD SCREENING MARKET SIZE, BY COLORIMETRIC IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD SCREENING MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAL-TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD SCREENING MARKET SIZE, BY TRANSCRIPTION-MEDIATED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD SCREENING MARKET SIZE, BY NGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD SCREENING MARKET SIZE, BY RAPID TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD SCREENING MARKET SIZE, BY WESTERN BLOT ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD SCREENING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 308. RUSSIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 309. RUSSIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 316. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 331. SPAIN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 332. SPAIN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 333. SPAIN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 339. SWEDEN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 340. SWEDEN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 341. SWEDEN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 346. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 348. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 350. TURKEY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 351. TURKEY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 352. TURKEY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 353. TURKEY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 354. TURKEY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 355. TURKEY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 356. TURKEY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 357. TURKEY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 361. UNITED ARAB EMIRATES BLOOD SCREENING MARKE